𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A patient with Smith–Lemli–Opitz syndrome: novel mutation of theDHCR7gene and effects of therapy with simvastatin and cholesterol supplement

✍ Scribed by Gabriella P. Szabó; Anna V. Oláh; Libor Kozak; Erzsébet Balogh; Andrea Nagy; Ivona Blahakova; Éva Oláh

Publisher
Springer
Year
2009
Tongue
English
Weight
70 KB
Volume
169
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical effects of cholesterol suppleme
Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS)
✍ Elias, Ellen R.; Irons, Mira B.; Hurley, Anne D.; Tint, G. Stephen; Salen, Geral 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

We describe the clinical effects of cholesterol supplementation in 6 children with the RSH-"Smith-Lemli-Opitz" syndrome (SLOS). The children ranged in age from birth to 11 years at the onset of therapy, with pretreatment cholesterol levels ranging from 8 to 62 mg/dl. Clinical benefits of therapy wer

Identification of nine novel DHCR7 misse
Identification of nine novel DHCR7 missense mutations in patients with Smith-Lemli-Opitz syndrome (SLOS)
✍ John S. Waye; Patrycja A. Krakowiak; Christopher A. Wassif; Allison L. Sterner; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive, multiple congenital anomaly syndrome caused by deficiency of 7-dehydrocholesterol reductase (DHCR7), which catalyzes the last step of endogenous cholesterol synthesis. Surveys of SLOS patients have identified more than one hundred point mu